177 related articles for article (PubMed ID: 32243963)
1. Development and evaluation of TPGS/PVA-based nanosuspension for enhancing dissolution and oral bioavailability of ticagrelor.
Na YG; Pham TMA; Byeon JJ; Kim MK; Han MG; Baek JS; Lee HK; Cho CW
Int J Pharm; 2020 May; 581():119287. PubMed ID: 32243963
[TBL] [Abstract][Full Text] [Related]
2. Strategic approach to developing a self-microemulsifying drug delivery system to enhance antiplatelet activity and bioavailability of ticagrelor.
Na YG; Byeon JJ; Wang M; Huh HW; Son GH; Jeon SH; Bang KH; Kim SJ; Lee HJ; Lee HK; Cho CW
Int J Nanomedicine; 2019; 14():1193-1212. PubMed ID: 30863054
[TBL] [Abstract][Full Text] [Related]
3. Statistical approach for solidifying ticagrelor loaded self-microemulsifying drug delivery system with enhanced dissolution and oral bioavailability.
Na YG; Byeon JJ; Wang M; Huh HW; Kim MK; Bang KH; Han MG; Lee HK; Cho CW
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109980. PubMed ID: 31500011
[TBL] [Abstract][Full Text] [Related]
4. A novel composition of ticagrelor by solid dispersion technique for increasing solubility and intestinal permeability.
Kim SJ; Lee HK; Na YG; Bang KH; Lee HJ; Wang M; Huh HW; Cho CW
Int J Pharm; 2019 Jan; 555():11-18. PubMed ID: 30448313
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R
Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174
[TBL] [Abstract][Full Text] [Related]
6. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability.
Kim DS; Kim DW; Kim KS; Choi JS; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Jin SG; Choi HG
Colloids Surf B Biointerfaces; 2016 Nov; 147():250-257. PubMed ID: 27518457
[TBL] [Abstract][Full Text] [Related]
8. Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate.
Qiao H; Chen L; Rui T; Wang J; Chen T; Fu T; Li J; Di L
Int J Nanomedicine; 2017; 12():1033-1046. PubMed ID: 28223797
[TBL] [Abstract][Full Text] [Related]
9. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
[No Abstract] [Full Text] [Related]
10. Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies.
Patel HP; Chaudhari PS; Gandhi PA; Desai BV; Desai DT; Dedhiya PP; Vyas BA; Maulvi FA
Int J Pharm; 2021 May; 600():120474. PubMed ID: 33737093
[TBL] [Abstract][Full Text] [Related]
11. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
12. Self-nanoemulsifying drug delivery system of cefpodoxime proxetil containing tocopherol polyethylene glycol succinate.
Bajaj A; Rao MR; Khole I; Munjapara G
Drug Dev Ind Pharm; 2013 May; 39(5):635-45. PubMed ID: 22564007
[TBL] [Abstract][Full Text] [Related]
13. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
[TBL] [Abstract][Full Text] [Related]
14. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
Gajera BY; Shah DA; Dave RH
Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, and pharmacokinetics study of a novel genistein-loaded mixed micelles system.
Shen H; He D; Wang S; Ding P; Wang J; Ju J
Drug Dev Ind Pharm; 2018 Sep; 44(9):1536-1542. PubMed ID: 29848136
[TBL] [Abstract][Full Text] [Related]
16. Development of a long-acting tablet with ticagrelor high-loaded nanostructured lipid carriers.
Jung M; Jin M; Jeon WJ; Lee H; Kim H; Won JH; Yoo H; Bai HW; Han SC; Suh H; Kang KU; Lee HK; Cho CW
Drug Deliv Transl Res; 2023 May; 13(5):1212-1227. PubMed ID: 35794353
[TBL] [Abstract][Full Text] [Related]
17. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
[TBL] [Abstract][Full Text] [Related]
18. Dissolution and bioavailability of lercanidipine-hydroxypropylmethyl cellulose nanoparticles with surfactant.
Ha ES; Choo GH; Baek IH; Kim JS; Cho W; Jung YS; Jin SE; Hwang SJ; Kim MS
Int J Biol Macromol; 2015 Jan; 72():218-22. PubMed ID: 25159878
[TBL] [Abstract][Full Text] [Related]
19. A cost-effective method to prepare curcumin nanosuspensions with enhanced oral bioavailability.
Wang Y; Wang C; Zhao J; Ding Y; Li L
J Colloid Interface Sci; 2017 Jan; 485():91-98. PubMed ID: 27657837
[TBL] [Abstract][Full Text] [Related]
20. Rutin nanosuspension for potential management of osteoporosis: effect of particle size reduction on oral bioavailability,
Gera S; Pooladanda V; Godugu C; Swamy Challa V; Wankar J; Dodoala S; Sampathi S
Pharm Dev Technol; 2020 Oct; 25(8):971-988. PubMed ID: 32403972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
